Inhibition of ADRP prevents diet-induced insulin resistance

Gladys M. Varela, Daniel A. Antwi, Ravindra Dhir, Xiaoyan Yin, Neel S. Singhal, Mark J. Graham, Roseanne M. Crooke, Rexford S Ahima

Research output: Contribution to journalArticle

Abstract

Diets with high fat content induce steatosis, insulin resistance, and type 2 diabetes. The lipid droplet protein adipose differentiation-related protein (ADRP) mediates hepatic steatosis, but whether this affects insulin action in the liver or peripheral organs in diet-induced obesity is uncertain. We fed C57BL/6J mice a high-fat diet and simultaneously treated them with an antisense oligonucleotide (ASO) against ADRP for 4 wk. Glucose homeostasis was assessed with clamp and tracer techniques. ADRP ASO decreased the levels of triglycerides and diacylglycerol in the liver, but fatty acids, long-chain fatty acyl CoAs, ceramides, and cholesterol were unchanged. Insulin action in the liver was enhanced after ADRP ASO treatment, whereas muscle and adipose tissue were not affected. ADRP ASO increased the phosphorylation of insulin receptor substrate (IRS)1, IRS2, and Akt, and decreased gluconeogenic enzymes and PKCε, consistent with its insulin-sensitizing action. These results demonstrate an important role for ADRP in the pathogenesis of diet-induced insulin resistance.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume295
Issue number3
DOIs
StatePublished - Sep 2008
Externally publishedYes

Fingerprint

Insulin Resistance
Antisense Oligonucleotides
Diet
Liver
High Fat Diet
Insulin
Insulin Receptor Substrate Proteins
Ceramides
Diglycerides
Inbred C57BL Mouse
Type 2 Diabetes Mellitus
Perilipin-2
Adipose Tissue
Triglycerides
Homeostasis
Fatty Acids
Obesity
Cholesterol
Phosphorylation
Glucose

Keywords

  • Adipose differentiation-related protein
  • Liver
  • Steatosis

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology (medical)
  • Physiology
  • Hepatology

Cite this

Inhibition of ADRP prevents diet-induced insulin resistance. / Varela, Gladys M.; Antwi, Daniel A.; Dhir, Ravindra; Yin, Xiaoyan; Singhal, Neel S.; Graham, Mark J.; Crooke, Roseanne M.; Ahima, Rexford S.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 295, No. 3, 09.2008.

Research output: Contribution to journalArticle

Varela, Gladys M. ; Antwi, Daniel A. ; Dhir, Ravindra ; Yin, Xiaoyan ; Singhal, Neel S. ; Graham, Mark J. ; Crooke, Roseanne M. ; Ahima, Rexford S. / Inhibition of ADRP prevents diet-induced insulin resistance. In: American Journal of Physiology - Gastrointestinal and Liver Physiology. 2008 ; Vol. 295, No. 3.
@article{0897a55170564e0f8d2b30a30c59d0ff,
title = "Inhibition of ADRP prevents diet-induced insulin resistance",
abstract = "Diets with high fat content induce steatosis, insulin resistance, and type 2 diabetes. The lipid droplet protein adipose differentiation-related protein (ADRP) mediates hepatic steatosis, but whether this affects insulin action in the liver or peripheral organs in diet-induced obesity is uncertain. We fed C57BL/6J mice a high-fat diet and simultaneously treated them with an antisense oligonucleotide (ASO) against ADRP for 4 wk. Glucose homeostasis was assessed with clamp and tracer techniques. ADRP ASO decreased the levels of triglycerides and diacylglycerol in the liver, but fatty acids, long-chain fatty acyl CoAs, ceramides, and cholesterol were unchanged. Insulin action in the liver was enhanced after ADRP ASO treatment, whereas muscle and adipose tissue were not affected. ADRP ASO increased the phosphorylation of insulin receptor substrate (IRS)1, IRS2, and Akt, and decreased gluconeogenic enzymes and PKCε, consistent with its insulin-sensitizing action. These results demonstrate an important role for ADRP in the pathogenesis of diet-induced insulin resistance.",
keywords = "Adipose differentiation-related protein, Liver, Steatosis",
author = "Varela, {Gladys M.} and Antwi, {Daniel A.} and Ravindra Dhir and Xiaoyan Yin and Singhal, {Neel S.} and Graham, {Mark J.} and Crooke, {Roseanne M.} and Ahima, {Rexford S}",
year = "2008",
month = "9",
doi = "10.1152/ajpgi.90204.2008",
language = "English (US)",
volume = "295",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Inhibition of ADRP prevents diet-induced insulin resistance

AU - Varela, Gladys M.

AU - Antwi, Daniel A.

AU - Dhir, Ravindra

AU - Yin, Xiaoyan

AU - Singhal, Neel S.

AU - Graham, Mark J.

AU - Crooke, Roseanne M.

AU - Ahima, Rexford S

PY - 2008/9

Y1 - 2008/9

N2 - Diets with high fat content induce steatosis, insulin resistance, and type 2 diabetes. The lipid droplet protein adipose differentiation-related protein (ADRP) mediates hepatic steatosis, but whether this affects insulin action in the liver or peripheral organs in diet-induced obesity is uncertain. We fed C57BL/6J mice a high-fat diet and simultaneously treated them with an antisense oligonucleotide (ASO) against ADRP for 4 wk. Glucose homeostasis was assessed with clamp and tracer techniques. ADRP ASO decreased the levels of triglycerides and diacylglycerol in the liver, but fatty acids, long-chain fatty acyl CoAs, ceramides, and cholesterol were unchanged. Insulin action in the liver was enhanced after ADRP ASO treatment, whereas muscle and adipose tissue were not affected. ADRP ASO increased the phosphorylation of insulin receptor substrate (IRS)1, IRS2, and Akt, and decreased gluconeogenic enzymes and PKCε, consistent with its insulin-sensitizing action. These results demonstrate an important role for ADRP in the pathogenesis of diet-induced insulin resistance.

AB - Diets with high fat content induce steatosis, insulin resistance, and type 2 diabetes. The lipid droplet protein adipose differentiation-related protein (ADRP) mediates hepatic steatosis, but whether this affects insulin action in the liver or peripheral organs in diet-induced obesity is uncertain. We fed C57BL/6J mice a high-fat diet and simultaneously treated them with an antisense oligonucleotide (ASO) against ADRP for 4 wk. Glucose homeostasis was assessed with clamp and tracer techniques. ADRP ASO decreased the levels of triglycerides and diacylglycerol in the liver, but fatty acids, long-chain fatty acyl CoAs, ceramides, and cholesterol were unchanged. Insulin action in the liver was enhanced after ADRP ASO treatment, whereas muscle and adipose tissue were not affected. ADRP ASO increased the phosphorylation of insulin receptor substrate (IRS)1, IRS2, and Akt, and decreased gluconeogenic enzymes and PKCε, consistent with its insulin-sensitizing action. These results demonstrate an important role for ADRP in the pathogenesis of diet-induced insulin resistance.

KW - Adipose differentiation-related protein

KW - Liver

KW - Steatosis

UR - http://www.scopus.com/inward/record.url?scp=53449099325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53449099325&partnerID=8YFLogxK

U2 - 10.1152/ajpgi.90204.2008

DO - 10.1152/ajpgi.90204.2008

M3 - Article

C2 - 18669627

AN - SCOPUS:53449099325

VL - 295

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 3

ER -